Table 1. Distribution of the number of months of isoniazid dispensed to each person initiating latent tuberculosis infection treatment (i.e., treatment persistence) and corresponding treatment completion categorizations (n = 662).
| # Months of Isoniazid within 1 Year Post-Initiation | Completed At Least a 6 Month Regimen? | Completed 9 Month Regimen? | Count of Persons | Percent | Cumulative Percent |
|---|---|---|---|---|---|
| ≥9 | Yes | Yes | 173 | 26.1% | 26.1% |
| 8 | Yes | No | 59 | 8.9% | 35.0% |
| 7 | Yes | No | 41 | 6.2% | 41.2% |
| 7* | No | No | 2 | 0.3% | 41.5% |
| 6 | Yes | No | 54 | 8.2% | 49.7% |
| 6* | No | No | 9 | 1.4% | 51.1% |
| 5 | No | No | 45 | 6.8% | 57.9% |
| 4 | No | No | 42 | 6.3% | 64.2% |
| 3 | No | No | 59 | 8.9% | 73.1% |
| 2 | No | No | 49 | 7.4% | 80.5% |
| 1 | No | No | 129 | 19.5% | 100.0% |
* Treatment completion of a 6-month isoniazid regimen requires the receipt of at least 180 doses in the 9-month period after treatment initiation [33]. People represented by these rows received at least 180 doses, but not within the 9-month post-initiation period. Additional details describing the dispensation patterns for these persons is available in S1 Table.